CANF - Can-Fite BioPharma Ltd.

NYSE American - Nasdaq Real Time Price. Currency in USD
Show:
Annual

Balance Sheet

All numbers in thousands
Breakdown
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Assets
Current Assets
Cash
Cash And Cash Equivalents
2,978
4,390
8,268
2,697
Other Short Term Investments
5,001
14,749
75
64
Total Cash
7,979
19,139
8,343
2,761
Other Current Assets
1,170
-
-
-
Total Current Assets
9,157
20,068
9,400
7,144
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
126
185
343
326
Accumulated Depreciation
-248
-234
-220
-208
Net property, plant and equipment
126
185
123
118
Total non-current assets
126
185
123
1,030
Total Assets
9,283
20,253
9,523
8,174
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Accounts Payable
896
954
561
2,156
Accrued liabilities
283
302
235
445
Deferred revenues
783
818
334
469
Total Current Liabilities
2,502
2,730
1,269
3,271
Non-current liabilities
Deferred revenues
2,295
3,070
2,156
2,422
Total non-current liabilities
2,309
3,141
2,180
2,461
Total Liabilities
4,811
5,871
3,449
5,732
Stockholders' Equity
Common Stock
0
60,654
33,036
8,225
Retained Earnings
-150,847
-140,674
-125,469
-110,311
Accumulated other comprehensive income
1,127
1,127
1,127
1,127
Total stockholders' equity
4,472
14,382
6,074
2,442
Total liabilities and stockholders' equity
9,283
20,253
9,523
8,174